DexCom has underperformed the broader market over the past year, while analysts remain strongly optimistic about its future prospects.
Intel (INTC) stock drops 32% from its June peak. Mizuho analyst cuts price target to $92 amid dilution concerns despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results